Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. - Wikidata - awgldk - TriplyDB

Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk.

Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk.

http://www.wikidata.org/entity/Q37372203

about

Vascular Complications of Cancer Chemotherapy The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo Noninvasive imaging of cardiovascular injury related to the treatment of cancer Potential Therapeutic Strategies for Hypertension-Exacerbated Cardiotoxicity of Anticancer Drugs UK guidelines for the management of soft tissue sarcomas Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelines Chemotherapy-Induced Cardiotoxicity: Pathophysiology and Prevention Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.Effect of radiotherapy after breast-conserving surgery in older patients with early breast cancer and breast ductal carcinoma in situ: a meta-analysis.Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines Heart repolarization changes after anthracycline therapy in the children with cancer Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy.Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas Hormone therapy with tamoxifen reduces plasma levels of NT-B-type natriuretic peptide but does not change ventricular ejection fraction after chemotherapy in women with breast cancer Four-dimensional phase contrast MRI with accelerated dual velocity encoding.Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer.Association between parity and obesity in Mexican and Mexican-American women: findings from the Ella binational breast cancer study Cardiotoxicity of cancer therapeutics: current issues in screening, prevention, and therapy.Shared Risk Factors in Cardiovascular Disease and Cancer.Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin.Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.Sequence-dependent combination therapy with doxorubicin and a survivin-specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma.Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper.Is cardiotoxicity being adequately assessed in current trials of cytotoxic and targeted agents in breast cancer?Do anthracyclines still have a role in adjuvant chemotherapy of breast cancer?Cardiotoxicity associated with targeting kinase pathways in cancer.Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines.The structure of anthracycline derivatives determines their subcellular localization and cytotoxic activity.Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy.How I treat acute myeloid leukemia presenting with preexisting comorbidities.Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention.Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the Netherlands.The clinical impact of a cardiologic follow-up in breast cancer survivors: an observational study.Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin.Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens.

P2860

Q26766269-DC51DF68-8DE6-41B8-8480-052298E99E4F Q26827175-B2CF36FA-FFE2-49DD-B483-A6C95051CD16 Q27024715-BC5BC963-3EDC-4CB6-A1A6-7936AD308B3E Q28070311-849CFDB6-08D9-4590-B891-78978F764D70 Q28076730-AD882892-DB7D-4CB7-80F7-6A13DFCE4D3F Q28080469-79B4BDC9-BC93-4CE8-A490-9F9AA2ABF4F4 Q30399577-F41BAFC1-C541-49B7-A0F0-57E10778B5F1 Q33404677-F9ABCCB2-2304-47AF-9E8B-4CCBB3FCB5EE Q33618312-33E9BF96-348F-4DAA-A661-CE2F6399CEDA Q33709640-B33C1C78-8975-48B8-928B-8A575076524A Q33710233-CFCE6FA2-EB91-4814-82EB-E684A171139A Q34023749-ABE1740B-4B74-47E5-8BED-70F6F1CC2698 Q34234872-470EAE56-64D8-4F0E-ADE1-D36FBC8D2336 Q34625462-9D08D286-E2F2-4FA2-B1C8-6B21AFEE7FBD Q34670913-7CAF831C-6445-415A-93F9-2A037FECB294 Q35062498-E0C56330-D37D-4B8D-9C61-30ABBE63D70E Q35931288-C75709F6-9B75-4ED5-A012-FB939B05078D Q36212048-F04BCFB1-284B-4ABC-8EFB-F00AA55D60F8 Q36312833-C5087163-029A-4F34-9471-1E2145EE4941 Q36676062-888129F5-2729-4D84-80B9-935C6126D1F8 Q36709155-5C11D951-107B-4DC2-B14B-3648B118C377 Q36804526-8FAA48A6-87D7-44F8-AE79-329094909ED7 Q37355919-E460AB2E-ADE4-40B5-9FDA-D522D78024F0 Q37560059-FBF2098A-5420-40BB-8963-EE7671DA3ED9 Q37625849-3DC9BC7F-1D34-4F96-A49C-E82DCD50BA70 Q37706355-E98D7713-FE84-4A9A-AE66-12B39665F575 Q37801220-489CC0DD-7C81-47E5-A215-340FC23385EF Q37811648-212A4183-A118-40BF-9B8C-F92FD943A1F2 Q37822734-B6887572-7B41-4413-901B-78066CA13A99 Q37823035-1CD666BB-CEA8-436B-9C51-95BC71A813E3 Q38576762-C354B64E-6ADA-4672-9B0E-C38086168BDA Q39781180-6D8383EF-ADA1-4498-9CFB-EA6798DBCDA9 Q39898360-53C1AAFF-7B45-485F-A83E-700887D145F6 Q41107043-78139D34-B951-42CC-8298-88A70052E418 Q41288150-64759E29-129E-4517-BCA7-4637F70A579A Q43796802-8D8BAEDE-992C-4451-BE9F-92312B649AE3 Q43958676-82129862-600B-412E-8706-96997242F1EE Q45925907-086151DD-2987-4B16-8A50-65971083F946 Q54967616-FAD0C90E-2B7D-4DCB-8B77-ED573B4BF316

P2860

Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk.

http://www.wikidata.org/entity/Q37372203

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Expert opinion on the use of a ...... breast cancer at cardiac risk.

@en

Expert opinion on the use of a ...... breast cancer at cardiac risk.

@nl

type

label

Expert opinion on the use of a ...... breast cancer at cardiac risk.

@en

Expert opinion on the use of a ...... breast cancer at cardiac risk.

@nl

prefLabel

Expert opinion on the use of a ...... breast cancer at cardiac risk.

@en

Expert opinion on the use of a ...... breast cancer at cardiac risk.

@nl

P1433

Q37372203-6141DB40-37BC-4F86-B050-1700021D8BFE

P1476

Q37372203-D364F7C0-02AA-4FB5-AFE0-61F9825E9473

P2093

Q37372203-03190D30-D07C-40F6-B070-02153361395C

Q37372203-12F5B8C7-4222-4819-952F-B52161C2B4A7

Q37372203-21FC6995-A5C7-4397-BA87-58D92C73EE3A

Q37372203-2E7F56DB-FF3E-420F-947B-9295BC58D216

Q37372203-44843254-1504-4B99-B2FF-C1449C8042B4

Q37372203-699A8088-C0A2-4555-A862-7088D6C52AA5

Q37372203-A16A36CE-EB65-4BE6-8A89-E8F854227E82

Q37372203-D3AE2D12-6CDA-42D3-A669-D16F95C76B27

Q37372203-E2A51748-8B3E-48D9-8374-A22CC03CE176

Q37372203-EB72E919-999B-4A2B-B8CD-38921CD64F27

P2860

Q37372203-08000903-FCC9-4D6E-B9F9-D666F2D62703

Q37372203-13E3BA4F-CB34-4D8B-B1A7-76D4A5F171E4

Q37372203-1528EF99-AE86-431A-BBA5-D165FF79BED7

Q37372203-1DB05383-2900-4D7B-84B9-C094734620E4

Q37372203-2545AADF-AE5B-44E7-9EF9-069C6F66B3F8

Q37372203-3005F14A-5345-4C57-8C48-72052AD2C59D

Q37372203-35F9CE16-106F-4E66-8588-3A1CAD116933

Q37372203-3EC58DB0-AD5C-4B89-A48E-D3348B89D8B0

Q37372203-41C07EDE-2968-436C-A87D-C35D0D4D25AE

Q37372203-4349A066-5713-4D6D-A706-26563F6E95BB

P304

Q37372203-6EFBBE5E-D17F-4A7A-BF83-E3DFBCD9B9D4

P31

Q37372203-153216BF-1068-4EED-AADD-91703FEFB679

P356

Q37372203-FE8D93ED-C52D-44C5-855A-6AE7F14B850B

P433

Q37372203-67411F62-272E-4FFA-AD4E-3B2917F7CC80

P478

Q37372203-4656B979-C3D6-4915-804D-DEC477AF3DB6

P577

Q37372203-F0EFC8C1-D8FD-4EBE-8A4F-2A897030808C

P5875

Q37372203-DD70CDD0-E881-476B-A8A4-4132847E0434

P698

Q37372203-467BD1F9-1D1E-4EF4-A2D9-BB7E88E0DDA2

P921

Q37372203-95DFBCDF-4189-4685-AEFB-BD8B7E65AF42

P356

P1433

Annals of Oncology

P1476

Expert opinion on the use of a ...... breast cancer at cardiac risk.

@en

P2093

A Jones

http://www.w3.org/2001/XMLSchema#string

A Stanley

http://www.w3.org/2001/XMLSchema#string

C Farrell

http://www.w3.org/2001/XMLSchema#string

C J Plummer

http://www.w3.org/2001/XMLSchema#string

C Palmieri

http://www.w3.org/2001/XMLSchema#string

J M Dixon

http://www.w3.org/2001/XMLSchema#string

M W Verrill

http://www.w3.org/2001/XMLSchema#string

N Murray

http://www.w3.org/2001/XMLSchema#string

P J Barrett-Lee

http://www.w3.org/2001/XMLSchema#string

R Leonard

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Interference of breast implants with echocardiographic image acquisition and interpretation.

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy.

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy.

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study.

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.

Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population.

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.

P304

816-827

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDN728

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23800834

http://www.w3.org/2001/XMLSchema#string

P698

19153118

http://www.w3.org/2001/XMLSchema#string

P921